Potential Use of Radiolabeled Glucuronide Prodrugs with Auger and/or Alpha Emitters in Combined Chemo- and Radio-Therapy of Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|6|11|1127-1142

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.6, Iss.11, 2000-07, pp. : 1127-1142

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combined Therapy for Gastrointestinal Carcinomas: Exploiting Synergies Between Gene Therapy and Classical Chemo-Radiotherapy

By  

Current Gene Therapy, Vol. 15, Iss. 2, 2015-04 ,pp. : 151-160

Bentham Science Publishers

Access to resources Recommend Favorite

Severe toxicity with combined pre-op radiotherapy + chemo

By  

Inpharma, Vol. 1, Iss. 1517, 2005-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Production of Alpha Emitters for Targeted Alpha Therapy

By  

Current Radiopharmaceuticals, Vol. 1, Iss. 3, 2008-09 ,pp. : 135-143

Bentham Science Publishers

Access to resources Recommend Favorite

The place of polymer prodrugs in cancer therapy

By Coxon F.Y.   Cassidy J.  

Expert Opinion on Emerging Drugs, Vol. 5, Iss. 4, 2000-12 ,pp. : 457-463

Informa Healthcare

Access to resources Recommend Favorite

Enzyme and Proton-Activated Prodrugs for a Selective Cancer Therapy

By  

Current Pharmaceutical Design, Vol. 9, Iss. 26, 2003-10 ,pp. : 2155-2175

Bentham Science Publishers

Access to resources Recommend Favorite